夏至草提取物对急性血瘀大鼠淋巴微循环的作用

目的:观察夏至草提取物(HLE)对急性血瘀大鼠淋巴微循环的作用.方法:(Dextran)以10ml/kg经静脉注射,1 min注完,诱导大鼠急性血瘀症模型,6 min后治疗组按1.0g/kg(含生药)从颈静脉注射HLE,对照组颈静脉注射等量的生理盐水,通过显微电视录像观察肠系膜微淋巴管(ML)收缩性的变化.结果:夏至草提取物使ML自主收缩频率、收缩活性指数(Index Ⅰ)、总收缩活性指数(IndexⅡ)、淋巴动力学指数(LD-Index)和血压显著高于对照组(P《0.05～0.01).结论:夏至草提取物对急性血瘀大鼠淋巴微循环障碍有非常好的改善作用.     

广藿香挥发油气相色谱指纹图谱再研究

目的:建立广藿香挥发油的特征指纹图谱,用于广藿香的品质控制及产地鉴别.方法:采用GC法对高要、石牌、吴川、遂溪、雷州及海南万年产广藿香挥发油进行GC图谱的比较分析.结果:以11个共有峰为评价指标,GC分析色谱条件的精密度、稳定性、重复性良好;同产地、不同采收期广藿香的主成分基本相同,但含量有差异;不同产地的广藿香其各组分的含量有较大的差异.结论:以11个共有峰作为广藿香挥发油特有的指纹图谱,以广藿香酮与广藿香醇的峰面积比值作为鉴别不同产地的广藿香的指标参数,建立了可用于广藿香道地性鉴别及品质评价的气相色谱指纹图谱标准.     

Ephedra alkaloid contents of Chinese herbal formulae sold in Taiwan

Consumption of Ephedra alkaloids is prohibited in‐competition by the World Anti‐Doping Agency (WADA). In Taiwan, colds are often treated with Chinese herbal formulae containing Herba Ephedrae. We screened products sold in Taiwan and preliminarily assessed their relationships with WADA threshold violations. Fifty‐six concentrated powder products, including 19 Chinese herbal formulae that contained Herba Ephedrae, were collected. The content of Ephedra alkaloids, namely ephedrine (E), methylephedrine (ME), norpseudoephedrine (NPE; cathine), pseudoephedrine (PE), and norephedrine (NE; phenylpropanolamine), was determined using a validated high‐performance liquid chromatography method. The results revealed that the phenotypic indicators of the collected products, E/PE and E/total ratios, were 1.52–4.70 and 0.49–0.72, respectively, indicating that the Herba Ephedrae species in these products was probably E. sinica or E. equisetina, but not E. intermedia. The contents of E, ME, NPE, PE, and NE and the total alkaloid contents in the daily doses of the products were 0.45–34.97, 0.05–4.87, 0.04–3.61, 0.15–12.09, and 0.01–2.00 mg and 0.68–53.64 mg, respectively. The alkaloid contents followed a relatively consistent order (E > PE > ME ≈ NPE > NE), even for products from different manufacturers. We calculated that single doses of 50.0% and 3.6% of the products would result in the WADA thresholds of E and NPE being exceeded, respectively. Our data provide critical information for athletes and medical personnel, who should be wary of using complex Chinese herbal formulae in addition to over‐the‐counter products.     

Anti-complementary effect of polysacchride B3-PS1 in Herba Scutellariae Barbatae (Scutellaria barbata)

The polysaccharide B3-PS1 was extracted and purified from Herba Scutellariae Barbatae (Scutellaria barbata D. Don), through bioactivity-guided fractionation. Average molecular weight of B3-PS1 was about 1,700,000?Da with a composition of Gal, Glc, Man and Ara in the ratio of 4.3:1.6:1.1:1.0, and trace of Rha, Fuc and Xyl. Preliminary data showed that 1) B3-PS1 inhibited complement activation of the classic pathway with CH₅₀ value of 0.12?±?0.02?mg/ml and of the alternative pathways with AP₅₀ value of 0.36?±?0.05?mg/ml; 2) B3-PS1 interacts with C1q, C1r, C1s, C2, C3, C4, C5 and C9 through a hemolytic assay. These results strongly suggested that B3-PS1 could be a potential candidate in treating those complement-associated diseases such as rheumatoid arthritis, Alzheimer’s disease, and Adult Respiratory Distress Syndrome (ARDS).     

不同产地肉苁蓉中麦角甾苷含量测定

目的测定同属肉苁蓉、管花肉苁蓉、盐生肉苁蓉及其不同产地药材中麦角甾苷含量。方法采取麦角甾苷稀甲醇溶液予200~400 nm波长扫描,以332 nm为检测波长。精密吸取对照品溶液1、2、4、6、8μL进样,按拟定的色谱条件测定。分别以乙酸乙酯、氯仿、石油醚、乙醚脱脂,然后以甲醇提取,测定含量。精密称取已测知含量的样品适量,添加适量麦角甾苷对照品并测定。结果麦角甾苷在0.1~0.8μg范围内与峰面积呈良好的线性关系。不同地区肉苁蓉麦角甾苷含量差异巨大。结论中药产地因素不可忽略,检测样品越多,含量变异程度越大。     

中药豨莶草的化学成分及其药理作用研究进展

目的探讨菊科植物豨莶草化学成分及其近年来药理作用研究进展。方法检索、整理、归纳国内外有关豨莶草化学成分及其药理作用研究文献。结果与结论豨莶草主要含有二萜类、倍半萜类、黄酮类等化学成分,豨莶草提取物及化学成分具有抗炎镇痛、抗过敏、心血管保护等生物活性。     

HPLC法测定一点红中槲皮苷的含量

目的:建立高效液相色谱法测定一点红中槲皮苷含量的方法。方法:采用Kromasil RP-C18色谱柱(4.6 mm×250 mm,5μm),以甲醇-0.1%磷酸溶液(55∶45)为流动相,流量1.0 m L·min-1,检测波长350 nm。结果:槲皮苷在11.40~114.0μg·m L-1范围内与峰面积成良好线性关系(r=0.999 8),平均加样回收率为97.80%,其RSD为1.95%(n=6)。结论:该法简便,专属性好,可作为一点红的质量控制方法。     

复方半枝莲防治二乙基亚硝胺诱发大鼠肝癌的研究

目的 :研究复方半枝莲 (SBC)对二乙基亚硝胺 (DEN)诱发大鼠肝癌的防治作用。方法 :利用免疫组化、流式细胞仪、血清和组织生化等检测方法 ,分别在第 14周和第 2 4周观察 SBC对 DEN诱发的肝癌形成过程的影响。结果 :中药组 14周时大鼠肝脏异型性增生灶明显较模型组少 ,2 4周时形成的肝癌结节小而少 ,模型组、中药组肝癌发生率分别为 75 .0 %、5 0 .0 % ;免疫组化显示中药组大鼠肝组织谷胱甘肽 - S-转移酶胎盘型阳性灶面积明显低于模型组 ;肝组织匀浆上清液谷胱甘肽 - S-转移酶含量以及血清 λ-谷氨酰转移酶、碱性磷酸酶、谷丙转氨酶含量也明显低于模型组 ;流式细胞仪检测结果显示 ,中药组大鼠肝细胞 G0 - G1 期比例下降 ,G2 - M期比例升高。结论 :SBC能抑制癌前病变 ,延缓肝癌的形成 ,降低肝癌发病率 ,其作用机制之一可能为阻滞 G2 - M期细胞进展 ,从而抑制DEN引起的肝细胞的去分化和恶性增殖     

经方中麻黄与石膏的配伍规律探析

通过对以麻黄和石膏为主要配伍的经方进行分析,归纳麻黄与石膏的主要配伍规律。认为麻黄与石膏既可相互制约,又可相互为用,通过剂量的调整和方中其他辅助药物的加减变化,二者配伍应用可以实现发汗清热兼顾、以发汗为主和以清热为主等不同治疗目的。     

HPLC法测定有瓜石斛中原儿茶酸的含量

目的:建立有瓜石斛中原儿茶酸的含量测定方法.方法:采用高效液相色谱(HPLC)法.色谱柱为Zorbax SB-Aq色谱柱;流动相为乙腈-0.1%磷酸溶液;检测波长为220nm;流速为1.0mL·min-1;柱温为30℃. 结果:原儿茶酸达到基线分离,线性关系良好(r=1.0000);平均加样回收率为101.71%,RSD为2.48%(n=6). 12批市售样品含量在0.0374~0.203mg·g-1范围内,差异相对较大. 结论:该方法灵敏,可靠,可用作有瓜石斛药材的质量评价指标之一.